Alcon to acquire aerie pharmaceuticals, inc., enhancing its ophthalmic pharmaceutical portfolio

Geneva & durham, n.c.--(business wire)--alcon (six/nyse: alc), the global leader in eye care dedicated to helping people see brilliantly, and aerie pharmaceuticals, inc. (nasdaq: aeri, “aerie”), a pharmaceutical company focused on the discovery, development, manufacturing and commercialization of first-in-class ophthalmic therapies, today announced the companies have entered into a definitive merger agreement through which alcon will acquire aerie. this transaction affirms alcon's commitment to
AERI Ratings Summary
AERI Quant Ranking